Phospholipase Inhibitors

Phospholipase A

PLD

Phospholipase C

Phospholipase Inhibitors, Antagonists, Activators & Substrates

Product Name	Phospholipase A	PLD	Phospholipase C	Purity
Ranakinin			PLC
Varespladib	sPLA2, IC₅₀: 9 nM			99.74%
Pyrrophenone	cPLA2α, IC₅₀: 4.2 nM			99.66%
FIPI		PLD1 PLD2		98.00%
Bromoenol lactone	PLA2, IC₅₀: 7 μM			99.59%
1-Naphthaleneacetic acid	PLA2, IC₅₀: 13.16 μM			99.65%
VU0359595		PLD1, IC₅₀: 3.7 nM PLD2, IC₅₀: 6.4 μM		98.06%
VU0155069		PLD1, IC₅₀: 46 nM PLD2, IC₅₀: 933 nM		98.55%
OBAA	PLA2, IC₅₀: 70 nM			99.31%
KH064	sPLA2, IC₅₀: 29 nM			99.84%
SB-435495	Lp-PLA2, IC₅₀: 0.06 nM			99.71%
OXA(17-33)		PLD1
Varespladib sodium	sPLA2, IC₅₀: 9 nM			98.83%
Giripladib	cPLA2α			99.68%
CAY10502	cPLA2α, IC₅₀: 4.3 nM			≥99.0%
Rapanone	PLA2, IC₅₀: 2.6 μM			99.93%
PACOCF3	PLA2, IC₅₀: 3.8 μM			98.0%
1-Naphthaleneacetic acid potassium salt	PLA2, IC₅₀: 13.16 μM			99.64%
VU533		PLD1, EC₅₀: 0.3 μM		99.84%
N-Palmitoyl-l-leucine	sPLA2			99.98%
Lp-PLA2-IN-1	Lp-PLA2			99.30%
Halopemide		PLD1, IC₅₀: 220 nM PLD2, IC₅₀: 310 nM		99.65%
trans-Benzylideneacetone	PLA2			99.87%
(S)-Bromoenol lactone	PLA2			99.1%
Alminoprofen	sPLA2			99.91%
A3373		PLD1, IC₅₀: 325 nM PLD2, IC₅₀: 15.15 μM		99.57%
BML-280		PLD2 PLD1		99.64%
Phospholipase C			PLC
Ochnaflavone	sPLA2, IC₅₀: 3.45 μM			98.30%
YM-26734	sPLA2			99.7%
FKGK11	PLA2			99.9%
LY433771	sPLA2, IC₅₀: 3 nM			99.8%
(Z)-Oleyloxyethyl phosphorylcholine	sPLA2			98.0%
Efipladib	cPLA2α, IC₅₀: 0.04 μM cPLA2α, Ki: 0.067 μM
VU 0364739 hydrochloride		PLD2, IC₅₀: 20 nM PLD1, IC₅₀: 1500 nM
CAY10590	sPLA2			98.0%
(2E)-OBAA	PLA2, IC₅₀: 70 nM
AZD2716	sPLA2			99.9%
FIPI hydrochloride		PLD1 PLD2
Lp-PLA2-IN-2	Lp-PLA2, IC₅₀: 120 nM
VI-60	cPLA₂
LY256548	PLA2
VU0155069 hydrochloride		PLD1, IC₅₀: 46 nM
SB-435495 hydrochloride	Lp-PLA2, IC₅₀: 0.06 nM
Protizinic acid	PLA2, IC₅₀: 210 μM
PC(O-16:0/18:2(9Z,12Z))	PLA2
Parameritannin A-1	PLA2
M119			PLC
AX048	cPLA₂
BMS-229724	cPLA₂
WAY-196025	cPLA2α, IC₅₀: 0.01 μM cPLA2α, Kd: 0.013 μM
ML256	Lp-PLA2
AGN-190383	PLA2
Ro 23-9358	PLA2
ASM-IN-2			PLC, IC₅₀: 0.87 μM
Manoalogue	sPLA2
Lp-PLA2-IN-14	rhLp-PLA2, pIC₅₀: 8.4
U 84569			PLC
sPLA2 inhibitor 2	sPLA2, IC₅₀: 0.0475 μM
SB-435495 ditartrate	Lp-PLA2, IC₅₀: 0.06 nM
LY 178002	PLA2, IC₅₀: 6.3 μM			99.60%
Me-Indoxam	sPLA2
SHP1-IN-2			PLC
PLA2-IN-1	PLA2, IC₅₀: 1 nM
Cinatrin C2	PLA2, IC₅₀: 800 μM
BAPTA tetracesium			PLC
Cinatrin C3	PLA2, IC₅₀: 70 μM
Cinatrin C1	PLA2
Darapladib analog-1	Lp-PLA2

Name
Email *

	Sorry, but the email address you supplied was invalid.